Robust and sustained efficacy in both adult PKD patients up to 30 months post-RP-L301; first pediatric patient results suggest efficacy similar to adult cohort with initial greater than five-point increase in hemoglobin Sustained genetic correction observed in eight of 12 evaluable Fanconi Anemia patients, and phenotypic correction and concomitant hematologic […]
Coronary/Structural Heart
NEW LATE-BREAKING DATA REINFORCE THE BENEFITS OF ABBOTT’S TRICLIP™ DEVICE FOR PEOPLE WITH TRICUSPID VALVE DISEASE
Data presented at EuroPCR 2023 build on prior study results demonstrating TriClip is a safe and effective therapy to treat leaky tricuspid valves Findings from the largest real-world dataset for tricuspid repair show device reduces tricuspid regurgitation and improves quality of life ABBOTT PARK, Ill., May 17, 2023 — Abbott […]
inHEART RECEIVES CE CERTIFICATION UNDER NEW MDR FOR NOVEL, AI-BASED, DIGITAL TWIN OF THE HEART
inHEART solution creates digital 3D models of the heart with unprecedented anatomical details, allowing physicians to better plan and personalize cardiac ablation procedures CAMBRIDGE, Mass. and PESSAC, France, May 18, 2023 /PRNewswire/ — inHEART, a privately-held medical device company delivering the world’s most advanced digital twin of the patient’s heart, announced today that it […]
New Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in Heart Failure Outcomes
Daxor’s BVA Technology Shown to Provide Unique and Individualized Data for Patient Management Oak Ridge, TN, May 18, 2023 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces new data demonstrating the importance and clinical utility of Daxor’s BVA-100 blood test in heart failure […]
AstraZeneca, Bellvitge University Hospital begin pilot of Cordio Medical’s app that monitors heart failure by voice
The HearO™ app predicts possible complications in patients with heart failure through speech, detecting the accumulation of fluid related to the disease. As leaders in digital health, Hospital Bellvitge and AstraZeneca are blazing a trail for other healthcare providers to efficiently implement the HearO app across unique healthcare systems.” — […]
DATA FROM BENCHMARK REGISTRY DEMONSTRATE IMPROVED TAVR EFFICIENCY WITH PRESERVED PATIENT SAFETY
PARIS, May 17, 2023 /PRNewswire/ — Edwards Lifesciences (NYSE: EW) announced today that new data from the Benchmark Registry in Europe demonstrated the safety and effectiveness of this streamlined treatment pathway for patients receiving transcatheter aortic valve replacement (TAVR) with balloon-expandable valves. The data were presented in a late-breaking clinical data session at EuroPCR 2023. […]
US Heart & Vascular’s Partnership with Memorial Katy Cardiology Associates Expands Delivery of Quality Cardiovascular Care to the Houston Area
The Memorial Katy Cardiology Partnership is a part of USHV’s 4th in Houston. NASHVILLE, Tenn.–(BUSINESS WIRE)–US Heart & Vascular (“USHV”), a leading national provider of support services to cardiovascular physician practices, announces its partnership with Memorial Katy Cardiology Associates (“Memorial Katy” or “MKCA”), a Houston-based cardiovascular physician practice focused on […]
ROBOCATH LAUNCHES NEW ROBOTIC PLATFORM R-ONE+
Rouen, France, May 16, 2023 – Robocath, a company that designs, develops and commercializes smart robotic solutions for the treatment of cardiovascular diseases, today announces the launch of its latest robotic platform – the R-One+. Robocath will showcase this new solution during the upcoming international EuroPCR conference in Paris (France), from May 16 […]
Cardio Diagnostics Holdings, Inc’s Actionable Clinical IntelligenceTM (ACI) Platform Offers New Epigenetic and Genetic Insights to Inform Coronary Heart Disease Management
CHICAGO–(BUSINESS WIRE)–Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, announced the introduction of the Actionable Clinical IntelligenceTM (ACI) platform to expand the information available to clinicians prescribing the Epi+Gen CHD and PrecisionCHD laboratory developed tests (LDTs). ACI offers new data-driven insights into the epigenetic and genetic molecular […]
Impulse Dynamics Announces 9,000th Patient Milestone Achieved With CCM® Therapy for Heart Failure
Momentum Continues as Depth of Clinical Experience Expands Worldwide MARLTON, N.J., May 15, 2023 (GLOBE NEWSWIRE) — Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), announced today a worldwide milestone achievement with the 9,000th patient receiving the Optimizer® system for […]



